Recent Articles

• 
  Biotech

  Engineer Raises KRW 10 Billion for Cell-Based Drug Tests

  On 9 January, Celloid CEO Kim Dong-sung explains well-cultivated mini organs while holding a three-dimensional culture automation system at the company’s research lab in Seocho-gu, Seoul. Mini organs grown in this system show better maturation of vasculature and tissue function compared with convent

  2026.02.21
• 
  AI Biotech

  Alke: AI, Not Intuition, to Optimize Drug Production

  ※ The Entrepreneurship Support Group of Seoul National University of Science and Technology operates a variety of support programs to help startups grow, including the Preliminary and Early Startup Packages and collaboration programs with global companies. IT Donga introduces promising startups that

  2026.02.20
• 
  Clinical Trial

  LG Chem Sets Dose for Phase 3 Head, Neck Cancer Drug

  LG Chem announced on the 20th that it has selected 20mg/kg, the maximum dose, as the final appropriate dosage for its new head and neck cancer drug “ficlatuzumab,” which is currently in Phase 3 clinical trials, and is continuing the study. The clinical trial for ficlatuzumab is being conducted by AV

  2026.02.20
• 
  Biotech

  3Dmem Eyes Nano 3D Printing for Eco-Friendly, High-Performance Membrane Mass Production

  [IT Dong-A x Korea University] Korea University operates the “Crimson Startup Support Group,” a startup incubation and support organization under the direct supervision of the Vice President for Research. In cooperation with the Crimson Startup Support Group, it introduces promising Korea University

  2026.02.20
• 
  Global Business

  KRW 100 Trillion Animal Drug Market Fuels Yuyu Growth

  On the 19th, Yoo Won-sang, CEO of YuYu Pharma, poses for a photo with his companion cat “Rang-i” at the company’s headquarters in Jung-gu, Seoul. YuYu Pharma plans to secure a new growth engine by focusing on the animal pharmaceuticals market, such as cat atopic dermatitis, where drug supply lags be

  2026.02.20
• 
  DTx / Platform

  ‘AI Control Tower’ Enables 70% Stroke Care Within 90 Minutes

  Integrated Response Situation Room at Yongin Severance Hospital, where everything that happens in the hospital can be checked in real time. It also plays a major role in reducing the mortality rate of inpatients. Provided by Yongin Severance Hospital Yongin Severance Hospital, which faced the formid

  2026.02.19
• 
  Startup

  StressSolution Aims to Go Global With Healing Beat

  ※ Kyungpook National University Startup Support Group, together with SKT, operates the “Startup Leap Package (Large Enterprise Collaboration Track)” for startups. It promotes innovative growth by activating startups’ ideas and technological capabilities based on collaboration with large corporations

  2026.02.13
• 
  Healthcare

  AI Detects Hidden Risk Signals in Normal ECG

  CEO Choi Won-ik It is not uncommon for a person in their 50s who received a “normal” result from a health check-up to suffer a myocardial infarction a year later. A 10-second electrocardiogram (ECG) cannot reveal hidden risks. Artificial intelligence (AI) is now overcoming this limitation. As techno

  2026.02.13
• 
  Global Expansion

  Samsung Bio to Launch Eye Drug Ophuviz Next Year After U.S. Patent Deal

  A researcher at Samsung Bioepis conducts material analysis. (Provided by Samsung Bioepis)/News1 Samsung Bioepis has secured the right to sell “Opuviz,” a biosimilar (biopharmaceutical copy drug) of the blockbuster drug “Eylea,” which generates annual sales of KRW 14 trillion, in the United States st

  2026.02.12
• 
  AI Healthcare

  AI Healthcare Battle Reaches Korea, Aiding Obesity Patients

  Recently, global big tech companies such as Amazon, OpenAI, and Anthropic have been successively launching artificial intelligence (AI)-based health management tools and medical administration processing tools, intensifying competition in the “AI healthcare” space. Naver and Kakao, the two major dom

  2026.02.12